Twist Bioscience Corp (TWST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 122,670 | 148,591 | 183,049 | 201,373 | 210,437 |
| Marketable Securities | 49,001 | 49,358 | 49,385 | 49,425 | 46,710 |
| Receivables | 64,153 | 50,062 | 57,019 | 49,854 | 49,949 |
| Inventories | 33,515 | 32,924 | 28,309 | 25,938 | 20,860 |
| TOTAL | $323,439 | $303,882 | $332,966 | $339,776 | $338,442 |
| Non-Current Assets | |||||
| PPE Net | 111,226 | 105,119 | 102,283 | 95,351 | 97,143 |
| Investments And Advances | 68,087 | 54,337 | 54,337 | 54,337 | 0 |
| Intangibles | 95,191 | 95,357 | 95,620 | 95,883 | 99,762 |
| Other Non-Current Assets | 78,271 | 79,390 | 56,655 | 58,258 | 60,268 |
| TOTAL | $352,775 | $334,203 | $308,895 | $303,829 | $257,173 |
| Total Assets | $676,214 | $638,085 | $641,861 | $643,605 | $595,615 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 14,682 | 12,493 | 11,094 | 11,985 | 8,063 |
| Accrued Expenses | 94,851 | 42,240 | 66,490 | 48,507 | 44,490 |
| Other current liabilities | N/A | 13,466 | N/A | 11,077 | 7,205 |
| TOTAL | $119,976 | $80,441 | $91,406 | $87,070 | $74,976 |
| Non-Current Liabilities | |||||
| Long Term Debt | 15,000 | 15,000 | 15,000 | 15,000 | 15,000 |
| Other Non-Current Liabilities | 86,144 | 86,549 | 62,497 | 63,337 | 65,531 |
| TOTAL | $101,144 | $101,549 | $77,497 | $78,337 | $80,531 |
| Total Liabilities | $221,120 | $181,990 | $168,903 | $165,407 | $155,507 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 62,271 | 61,312 | 61,148 | 60,361 | 59,916 |
| Common Shares | 1 | N/A | N/A | N/A | N/A |
| Retained earnings | -1,394,106 | -1,350,085 | -1,319,578 | -1,292,440 | -1,312,830 |
| Other shareholders' equity | -639 | -571 | -627 | -864 | -662 |
| TOTAL | $455,094 | $456,095 | $472,958 | $478,198 | $440,108 |
| Total Liabilities And Equity | $676,214 | $638,085 | $641,861 | $643,605 | $595,615 |